Ingunn Munch Lindvig
General Counsel at BIOINVENT INTERNATIONAL AB
Profile
Ingunn Munch Lindvig is currently the Senior Vice President-Regulatory Affairs at BioInvent International AB since 2023.
Previously, she worked as the Head-Regulatory Affairs at Nordic Nanovector ASA and as the Vice President & Head-Regulatory Affairs at Circio Holding ASA. Dr. Lindvig holds a doctorate degree from the University of Oslo.
Ingunn Munch Lindvig active positions
| Companies | Position | Start |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | General Counsel | 2023-06-11 |
Former positions of Ingunn Munch Lindvig
| Companies | Position | End |
|---|---|---|
| THOR MEDICAL | General Counsel | - |
| CIRCIO HOLDING ASA | General Counsel | - |
Training of Ingunn Munch Lindvig
| University of Oslo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BIOINVENT INTERNATIONAL AB | Health Technology |
| CIRCIO HOLDING ASA | Health Technology |
| Private companies | 1 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
- Stock Market
- Insiders
- Ingunn Munch Lindvig
